Chronos Wealth Management LLC Buys 1,646 Shares of The Procter & Gamble Company (NYSE:PG)

Chronos Wealth Management LLC lifted its stake in The Procter & Gamble Company (NYSE:PGGet Rating) by 5.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,324 shares of the company’s stock after acquiring an additional 1,646 shares during the quarter. Procter & Gamble accounts for about 3.3% of Chronos Wealth Management LLC’s investment portfolio, making the stock its 16th largest holding. Chronos Wealth Management LLC’s holdings in Procter & Gamble were worth $4,360,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Vanguard Group Inc. grew its position in Procter & Gamble by 1.1% during the first quarter. Vanguard Group Inc. now owns 217,519,281 shares of the company’s stock valued at $33,236,946,000 after buying an additional 2,394,234 shares during the period. BlackRock Inc. boosted its position in shares of Procter & Gamble by 1.2% in the fourth quarter. BlackRock Inc. now owns 156,813,285 shares of the company’s stock worth $25,651,517,000 after purchasing an additional 1,785,863 shares during the period. State Street Corp boosted its position in shares of Procter & Gamble by 1.7% in the fourth quarter. State Street Corp now owns 105,458,164 shares of the company’s stock worth $17,250,846,000 after purchasing an additional 1,716,517 shares during the period. Bank of New York Mellon Corp boosted its position in shares of Procter & Gamble by 4.3% in the first quarter. Bank of New York Mellon Corp now owns 23,740,255 shares of the company’s stock worth $3,627,510,000 after purchasing an additional 983,197 shares during the period. Finally, Norges Bank bought a new position in shares of Procter & Gamble in the fourth quarter worth approximately $3,726,603,000. 63.45% of the stock is currently owned by institutional investors.

Procter & Gamble Trading Down 1.3 %

PG stock opened at $135.73 on Thursday. The company has a quick ratio of 0.45, a current ratio of 0.65 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a twelve month low of $129.50 and a twelve month high of $165.35. The stock has a market capitalization of $323.78 billion, a price-to-earnings ratio of 23.36, a price-to-earnings-growth ratio of 3.55 and a beta of 0.35. The firm’s fifty day simple moving average is $142.76 and its two-hundred day simple moving average is $147.31.

Procter & Gamble (NYSE:PGGet Rating) last posted its quarterly earnings data on Friday, July 29th. The company reported $1.21 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.02). Procter & Gamble had a net margin of 18.39% and a return on equity of 32.67%. The firm had revenue of $19.52 billion for the quarter, compared to the consensus estimate of $19.41 billion. During the same quarter last year, the firm earned $1.13 EPS. The company’s revenue was up 3.0% on a year-over-year basis. As a group, analysts anticipate that The Procter & Gamble Company will post 5.94 earnings per share for the current year.

Procter & Gamble Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 15th. Shareholders of record on Friday, July 22nd were given a dividend of $0.913 per share. This represents a $3.65 dividend on an annualized basis and a yield of 2.69%. The ex-dividend date was Thursday, July 21st. Procter & Gamble’s dividend payout ratio (DPR) is 62.82%.

Analysts Set New Price Targets

PG has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Procter & Gamble from $171.00 to $157.00 and set a “buy” rating for the company in a research report on Tuesday, June 21st. UBS Group lowered their target price on shares of Procter & Gamble to $153.00 in a report on Friday, July 22nd. Evercore ISI set a $170.00 target price on shares of Procter & Gamble in a report on Monday, June 20th. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Wednesday, September 14th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Procter & Gamble from $165.00 to $156.00 in a report on Thursday, July 21st. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $162.93.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Mary Theresa Grabowski sold 16,000 shares of the business’s stock in a transaction on Thursday, August 11th. The shares were sold at an average price of $147.00, for a total transaction of $2,352,000.00. Following the transaction, the insider now owns 4,326 shares in the company, valued at $635,922. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, insider Susan Street Whaley sold 907 shares of the company’s stock in a transaction dated Wednesday, August 17th. The shares were sold at an average price of $149.33, for a total value of $135,442.31. Following the transaction, the insider now directly owns 6,253 shares in the company, valued at $933,760.49. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Mary Theresa Grabowski sold 16,000 shares of the company’s stock in a transaction dated Thursday, August 11th. The stock was sold at an average price of $147.00, for a total transaction of $2,352,000.00. Following the completion of the transaction, the insider now owns 4,326 shares in the company, valued at $635,922. The disclosure for this sale can be found here. Insiders have sold 289,321 shares of company stock worth $42,559,426 over the last quarter. Insiders own 0.26% of the company’s stock.

Procter & Gamble Company Profile

(Get Rating)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGGet Rating).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.